bromodeoxyuridine has been researched along with Parkinson Disease in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 12 (85.71) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 1 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, HJ; Kim, HI; Kim, SH; Lim, J | 1 |
| Jing, X; Kondo, T; Miwa, H; Miyajima, M; Nakanishi, I; Sakaguchi, K; Sawada, T | 1 |
| Brismar, H; Carlen, M; Cassidy, RM; Delfani, K; Frisen, J; Janson, AM; Johansson, CB; Momma, S; Shupliakov, O; Zhao, M | 1 |
| Junn, E; Kim, YM; Lee, G; Lee, SS; Mouradian, MM; Park, KH; Quezado, MM; Ronchetti, RD; Tanaka, M | 1 |
| Besedovsky, H; del Rey, A; Depino, AM; Earl, C; Ferrari, C; Kaczmarczyk, E; Oertel, WH; Pitossi, FJ | 1 |
| Albéri, L; Sgadò, P; Simon, HH | 1 |
| Baker, KA; Baker, SA; Hagg, T | 1 |
| Leopold, C; Rafuse, VF; Robertson, HA; Soundararajan, P | 1 |
| Brundin, P; Frielingsdorf, H; Häggblad, J; Mohapel, P; Zachrisson, O | 1 |
| Hosman, K; Kempermann, G; Kupsch, A; Petrus, DS; Siebert, E; Steiner, B; Winter, C | 1 |
| Ma, J; Wang, H; Wang, YC | 1 |
| Aponso, PM; Connor, B; Faull, RL | 1 |
| Bernson, M; Darmopil, S; de Ceballos, ML; Moratalla, R; Muñetón-Gómez, VC | 1 |
| Daadi, MM | 1 |
14 other study(ies) available for bromodeoxyuridine and Parkinson Disease
| Article | Year |
|---|---|
ERRγ Ligand Regulates Adult Neurogenesis and Depression-like Behavior in a LRRK2-G2019S-associated Young Female Mouse Model of Parkinson's Disease.
Topics: Animals; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Depression; Disease Models, Animal; Doublecortin Domain Proteins; Estrogens; Female; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2; Ligands; Male; Mice; Mice, Transgenic; Mutation; Neurogenesis; Orphan Nuclear Receptors; Parkinson Disease; Protein Serine-Threonine Kinases; Tropomyosin | 2022 |
Ephrin-A1-mediated dopaminergic neurogenesis and angiogenesis in a rat model of Parkinson's disease.
Topics: Animals; Behavior, Animal; Bromodeoxyuridine; Cell Differentiation; Cell Movement; Cell Tracking; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Ephrin-A1; Ephrin-A4; Humans; Immunoglobulin Fc Fragments; Injections, Intraventricular; Lateral Ventricles; Mice; Neostriatum; Neovascularization, Physiologic; Neurogenesis; Neurons; Olfactory Bulb; Parkinson Disease; Rats; Receptors, Eph Family; Receptors, Fibroblast Growth Factor; Recombinant Fusion Proteins; Signal Transduction | 2012 |
Evidence for neurogenesis in the adult mammalian substantia nigra.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antimetabolites; Apoptosis; Bromodeoxyuridine; Dopamine; Dopamine Agents; Hippocampus; Humans; Male; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence; Neurons; Parkinson Disease; Stem Cells; Substantia Nigra; Synapses; Time Factors | 2003 |
Cell cycle aberrations by alpha-synuclein over-expression and cyclin B immunoreactivity in Lewy bodies.
Topics: alpha-Synuclein; Animals; Anti-Bacterial Agents; Blotting, Western; Brain; Bromodeoxyuridine; Cell Count; Cell Cycle; Cell Division; Clone Cells; Culture Media, Serum-Free; Cyclin B; Cyclin D3; Cyclins; DNA; Dose-Response Relationship, Drug; Doxycycline; Flow Cytometry; Humans; Immunohistochemistry; Lewy Bodies; Mitogen-Activated Protein Kinase 3; Mitogen-Activated Protein Kinases; Nerve Tissue Proteins; Neurodegenerative Diseases; Parkinson Disease; PC12 Cells; Rats; Synucleins; Time Factors; Transfection | 2003 |
Microglial activation with atypical proinflammatory cytokine expression in a rat model of Parkinson's disease.
Topics: Adrenergic Agents; Animals; Blotting, Northern; Bromodeoxyuridine; Corpus Striatum; Disease Models, Animal; Ectodysplasins; Endotoxins; Enzyme-Linked Immunosorbent Assay; Functional Laterality; Glial Fibrillary Acidic Protein; Glycoproteins; Immunohistochemistry; Inflammation; Interleukin-1; Lectins; Male; Membrane Proteins; Microglia; Oxidopamine; Parkinson Disease; Psychomotor Performance; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Substantia Nigra; Time Factors; Tumor Necrosis Factor-alpha; Tyrosine 3-Monooxygenase | 2003 |
Engrailed genes are cell-autonomously required to prevent apoptosis in mesencephalic dopaminergic neurons.
Topics: Animals; Apoptosis; Bromodeoxyuridine; Caspase 3; Caspases; Cell Death; Cells, Cultured; Coloring Agents; Disease Models, Animal; Dopamine; Gene Deletion; Gene Silencing; Homeodomain Proteins; Immunohistochemistry; Mesencephalon; Mice; Mice, Neurologic Mutants; Microscopy, Fluorescence; Mutation; Neurons; Oligonucleotides; Parkinson Disease; RNA Interference; RNA, Small Interfering; Time Factors; Transfection | 2004 |
Dopaminergic nigrostriatal projections regulate neural precursor proliferation in the adult mouse subventricular zone.
Topics: Animals; Bromodeoxyuridine; Cell Count; Cell Division; Corpus Striatum; Disease Models, Animal; Dopamine; Immunohistochemistry; Lateral Ventricles; Male; Mice; Mice, Inbred C57BL; Neurons; Oxidopamine; Parkinson Disease; Substantia Nigra; Tyrosine 3-Monooxygenase; Ventral Tegmental Area | 2004 |
Neuroprotective properties of cultured neural progenitor cells are associated with the production of sonic hedgehog.
Topics: Animals; Antimetabolites; Blotting, Western; Bromodeoxyuridine; Cell Count; Cell Survival; Cells, Cultured; Chick Embryo; Culture Media, Conditioned; Dopamine; Electrophoresis, Polyacrylamide Gel; Enzyme-Linked Immunosorbent Assay; Epidermal Growth Factor; Female; Hedgehog Proteins; Immunohistochemistry; Mice; Mice, Transgenic; Movement Disorders; Neurons; Oxidopamine; Parkinson Disease; Stem Cell Transplantation; Stem Cells; Sympatholytics; Trans-Activators | 2005 |
Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions.
Topics: Adrenergic Agents; Animals; Brain-Derived Neurotrophic Factor; Bromodeoxyuridine; Cell Count; Corpus Striatum; Disease Models, Animal; Doublecortin Protein; Drug Administration Routes; Drug Interactions; Female; Immunohistochemistry; Microscopy, Confocal; Neurons; Oxidopamine; Parkinson Disease; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Time Factors; Tyrosine 3-Monooxygenase | 2005 |
Enriched environment induces cellular plasticity in the adult substantia nigra and improves motor behavior function in the 6-OHDA rat model of Parkinson's disease.
Topics: Adrenergic Agents; Amphetamine; Analysis of Variance; Animals; Antigens; Behavior, Animal; Bromodeoxyuridine; Cell Count; Cell Proliferation; Central Nervous System Stimulants; Disease Models, Animal; Environment; Female; Fluorescent Antibody Technique; Glial Fibrillary Acidic Protein; Motor Activity; Neuronal Plasticity; Oxidopamine; Parkinson Disease; Proteoglycans; Rats; Rats, Sprague-Dawley; Substantia Nigra; Tyrosine 3-Monooxygenase | 2006 |
[Effects of Shuanggu Yitong needling method on proliferation and differentiation of nerve stem cells in the Parkinson's disease model rat].
Topics: Acupuncture Therapy; Animals; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Corpus Striatum; Male; Neurons; Parkinson Disease; Rats; Rats, Wistar; Stem Cells; Substantia Nigra | 2006 |
Increased progenitor cell proliferation and astrogenesis in the partial progressive 6-hydroxydopamine model of Parkinson's disease.
Topics: Adrenergic Agents; Adult Stem Cells; Analysis of Variance; Animals; Astrocytes; Bromodeoxyuridine; Cell Differentiation; Cell Proliferation; Corpus Striatum; Disease Models, Animal; Glial Fibrillary Acidic Protein; Male; Oxidopamine; Parkinson Disease; Rats; Rats, Wistar; Substantia Nigra; Time Factors; Tyrosine 3-Monooxygenase | 2008 |
Tyrosine hydroxylase cells appearing in the mouse striatum after dopamine denervation are likely to be projection neurones regulated by L-DOPA.
Topics: Animals; Biomarkers; Bromodeoxyuridine; Cell Count; Cell Proliferation; Corpus Striatum; Denervation; Dopamine; Dopamine Plasma Membrane Transport Proteins; Immunohistochemistry; Levodopa; Male; Mice; Mice, Inbred C57BL; Nerve Degeneration; Neural Pathways; Neurons; Opioid Peptides; Oxidopamine; Parkinson Disease; Proto-Oncogene Proteins c-fos; Substantia Nigra; Sympatholytics; Tyrosine 3-Monooxygenase | 2008 |
In vitro assays for neural stem cell differentiation.
Topics: Animals; Astrocytes; Biological Assay; Brain Tissue Transplantation; Bromodeoxyuridine; Cell Culture Techniques; Cell Differentiation; Cell Division; Cell Separation; Cells, Cultured; Coculture Techniques; Culture Media; Growth Substances; Neurons; Parkinson Disease; Phenotype; Stem Cells; Tyrosine 3-Monooxygenase | 2002 |